Product no. chemwillFLUMEG1020
Flunixin meglumine 42461-84-7 USP37 Manufacturer High quality Best price In stock factory Flunixin meglumin
USP37 GMP factory
Appearance White Crystalline powder
Identification 1) The IR absorption spectrum of the sample is concordant with that of Flunixin meglumine reference standard.
2) The retention times of main peak in the Chromatogram of Assay preparation corresponds to that in the Chromatogram of the Standard preparation,as obtained in the Assay
3) Ultraviolet absorption: 197U.As per USP standard
Melting Point 137 ~ 140℃ 137.5 ~ 138.50℃
Specific rotation -9 ~ -12° -11.5°
Residue on ignition ≤0.20% 0.09%
pH Value 7.0 ~ 9.0 8.8
Loss on drying ≤0.50% 0.29%
Heavy Metals ≤10ppm
comply with usp37/ ep8 /bpv2012
highly quality and immedaite delivery
package: 25.0kg net drum
main uses: mammalian anti-inflammatory analgesia, can alleviate muscle abnormalities caused by inflammation and pain, treatment of diarrhea, tremor, colitis, respiratory diseases, endotoxin-induced mastitis, arthritis, fever, diarrhea, tremor, eye infections, etc.
Route of synthesis
Product Name: Flunixin meglumine
Synonyms:
2-{[2-Methyl-3-(trifluoromethyl)phenyl]amino}nicotinic acid - 1-deoxy-1-(methylamino)-D-glucitol (1:1); 3-pyridinecarboxylic acid, 2-[[2-methyl-3-(trifluoromethyl)phenyl]amino]-, compd. with D-glucitol, 1-deoxy-1-(methylamino)- (1:1); 2-{[2-methyl-3-(trifluoromethyl)phenyl]amino}pyridine-3-carboxylic acid - 1-deoxy-1-(methylamino)-D-glucitol (1:1); 1-deoxy-1-(methylamino)-d-glucito-2-((2-methyl-3-(trifluoromethyl)phenyl)amino; Flunixin meglumin
CAS RN.:
42461-84-7
EINECS: 255-836-0
Molecular Weight: 491.4581
Molecular Formula: C21H28F3N3O7
Melting Point(℃): 136-138℃
Boiling Point(℃): 378.7°C at 760 mmHg
Flash Point(℃): 182.8°C
Water Solubility: soluble
HS Code 29339900
Cyclooxigenase inhibitor. Anti-inflammatory; analgesic; antipyretic.
Chemical Name flunixin meglumine
Synonyms
Flunixin Meglumine; 2-[[2-Methyl-3-(trifluoromethyl)phenyl]amino]-3-pyridinecarboxylic acid meglumine salt Banamine;
CAS No. 42461-84-7
Molecular Formula C21H28F3N3O7
Molecular Weight 491.45800
PSA 175.40000
LogP 0.95620
Properties
Appearance & Physical State solid
Density 1.403 g/cm3
Boiling Point 378.7ºC at 760 mmHg
Veterinary Drugs and Treatments In the United States, flunixin meglumine is approved for use in horses, cattle and swine; however, it is approved for use in dogs in other countries. The approved indications for its use in the horse are for the alleviation of inflammation and pain associated with musculoskeletal disorders and alleviation of visceral pain associated with colic. In cattle it is approved for the control of pyrexia associated with bovine respiratory disease and endotoxemia, and control of inflammation in endotoxemia. In swine, flunixin is approved for use to control pyrexia associated with swine respiratory disease.
Flunixin has been suggested for many other indications in various species, including: Horses: foal diarrheas, shock, colitis, respiratory disease, post-race treatment, and pre- and post ophthalmic and general surgery; Dogs: disk problems, arthritis, heat stroke, diarrhea, shock, ophthalmic inflammatory conditions, pre- and post ophthalmic and general surgery, and treatment of parvovirus infection; Cattle: acute respiratory disease, acute coliform mastitis with endotoxic shock, pain (downer cow), and calf diarrheas; Swine: agalactia/hypogalactia, lameness, and piglet diarrhea. It should be noted that the evidence supporting some of these indications is equivocal and flunixin may not be appropriate for every case.
Melting Point 136-138ºC
Flash Point 182.8ºC
China
